Through the Thicket and Across the Divide: Successfully Navigating the Regulatory Landscape in Life Sciences Research
暂无分享,去创建一个
[1] Brian Salter,et al. State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding 'Rising Powers' in the global context , 2011, Globalization and health.
[2] Gill Haddow,et al. Governing Risk, Engaging Publics, and Engendering Trust: New Horizons for Law and Social Science? , 2013 .
[3] Graeme Laurie,et al. Towards Principles–Based Approaches to Governance of Health–Related Research Using Personal Data , 2013, European Journal of Risk Regulation.
[4] Andrew Webster,et al. Bio-objects and their Boundaries: Governing Matters at the Intersection of Society, Politics, and Science , 2011, Croatian medical journal.
[5] Jennifer Couzin-Frankel,et al. Science Gold Mine, Ethical Minefield , 2009, Science.
[6] S. Harmon,et al. Solidarity: A (New) Ethic for Global Health Policy , 2006, Health Care Analysis.
[7] J. Black. Decentring Regulation: Understanding the Role of Regulation and Self-Regulation in a ‘Post-Regulatory’ World , 2001 .
[8] S. Harmon. Ambition and Ambivalence: Encouraging a "Sci-Tech Culture" in Argentina through Engagement and Regulatory Reform , 2011 .
[9] D. Butler. Translational research: Crossing the valley of death , 2008, Nature.
[10] S. Harmon,et al. Yearworth v. North Bristol NHS trust: a property case of uncertain significance? , 2010, Medicine, health care, and philosophy.
[11] Bob Wong,et al. Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots. , 2011, American journal of public health.
[12] Alex Faulkner,et al. Governing biological material at the intersection of care and research: the use of dried blood spots for biobanking , 2012, Croatian medical journal.
[13] G Laurie. Better to hesitate at the threshold of compulsion: PKU testing and the concept of family autonomy in Eire , 2002, Journal of medical ethics.
[14] D. Beyleveld,et al. Betrayal of Confidence in the Court of Appeal , 2000, Medical law international.
[15] Erin Rothwell,et al. Retention and Research Use of Residual Newborn Screening Bloodspots , 2013, Pediatrics.
[16] Denise Chrysler,et al. The Michigan BioTrust for Health: Using Dried Bloodspots for Research to Benefit the Community While Respecting the Individual , 2011, Journal of Law, Medicine & Ethics.
[17] Bettina Lange,et al. Introduction: Material Worlds: Intersections of Law, Science, Technology, and Society , 2012 .
[18] D. Hougaard,et al. Storage policies and use of the Danish Newborn Screening Biobank , 2007, Journal of Inherited Metabolic Disease.
[19] Shawn Harmon,et al. Regulation of Stem Cell and Regenerative Science: Stakeholder Opinions, Plurality and Actor Space in the Argentine Social/Science Setting , 2010 .
[20] Shawn Harmon,et al. Foresighting Futures: Law, New Technologies, and the Challenges of Regulating for Uncertainty , 2012 .
[21] Jeffrey Botkin,et al. State Laws Regarding the Retention and Use of Residual Newborn Screening Blood Samples , 2011, Pediatrics.
[22] Graeme Laurie,et al. RHETORIC OR REALITY: WHAT IS THE LEGAL STATUS OF THE CONSENT FORM IN HEALTH-RELATED RESEARCH?* , 2012, Medical law review.
[23] Shuyuan Hu. Minnesota Supreme Court hears whether the Genetic Privacy Act protects newborn blood spot samples obtained under the state's newborn screening statutes--Bearder v. State of Minnesota. , 2012, American journal of law & medicine.
[24] Shawn Harmon,et al. YEARWORTHv. NORTH BRISTOL NHS TRUST: PROPERTY, PRINCIPLES, PRECEDENTS AND PARADIGMS , 2010, The Cambridge Law Journal.